Travere Therapeutics, Inc. TVTX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$321.55M-189% | -$111.4M+60.0% | -$278.48M-54.6% | ||
| $60.74M+39.5% | $43.56M+13.0% | $38.53M+79.1% | $21.51M— | ||
| $44.87M+21.6% | $36.91M-16.6% | $44.25M+16.0% | $38.14M+29.0% | ||
| —— | $6M— | —— | $1.06M— | ||
| -$5.04M-234% | $3.77M-90.4% | $39.42M— | —— | ||
| —— | —— | $24.76M— | —— | ||
| $28.84M— | —— | —— | $22.18M+33.0% | ||
| $8.1M— | —— | $4.66M-10.4% | $5.2M— | ||
| -$9.7M— | —— | —— | —— | ||
| —— | -$8.27M— | —— | —— | ||
| —— | -$6.12M+61.2% | -$15.78M-22.0% | -$12.93M-132% | ||
| —— | -$237.48M+15.2% | -$280.02M-50.3% | -$186.29M— | ||
| $323.6M-0.8% | $326.33M-2.5% | $334.58M-12.4% | $381.99M-11.9% | ||
| $58.16M+60.6% | $36.21M-12.9% | $41.59M+46.6% | $28.37M+48.9% | ||
| —— | —— | —— | -$32.55M— | ||
| $0-100% | $134.74M-29.5% | $191.2M— | $0-100% | ||
| —— | $139.42M-36.4% | $219.39M+86.6% | $117.57M-49.3% | ||
| —— | -$913K-142% | $2.16M— | —— | ||
| —— | $359K+110% | -$3.51M+96.6% | -$104.07M-229% | ||
| $8.84M0.0% | $8.84M0.0% | $8.84M-13.0% | $10.16M+38.7% | ||
| $28.84M— | —— | —— | $22.18M+33.0% | ||
| $8.1M— | —— | $4.66M-10.4% | $5.2M— | ||
| —— | -$8.27M— | —— | —— | ||
| $404K+910% | $40K-94.0% | $668K-15.5% | $791K— | ||
| $58.16M+60.6% | $36.21M-12.9% | $41.59M+46.6% | $28.37M+48.9% | ||
| $323.6M-0.8% | $326.33M-2.5% | $334.58M-12.4% | $381.99M-11.9% | ||
| $14.28M-7.5% | $15.44M-4.8% | $16.21M+0.9% | $16.07M-17.0% | ||
| $6.58M+2.9% | $6.39M+1.2% | $6.32M+4.9% | $6.02M+173% | ||
| $2.1M0.0% | $2.1M0.0% | $2.1M0.0% | $2.1M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Travere Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Travere Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.